Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1996 Dec;64(12):5085–5091. doi: 10.1128/iai.64.12.5085-5091.1996

Migration of the fungal pathogen Candida albicans across endothelial monolayers.

S Zink 1, T Nass 1, P Rösen 1, J F Ernst 1
PMCID: PMC174492  PMID: 8945550

Abstract

Migration of the fungal pathogen Candida albicans across the endothelial cell layer is considered a prerequisite for the invasion of multiple organs occurring in systemic candidiasis. We developed an experimental system in which C. albicans migrates from a luminal compartment across a monolayer of bovine aortic endothelial cells on a porous filter support to an abluminal compartment. In this system, a C. albicans wild-type strain (ATCC 10261) traverses the endothelial monolayer in a time-, glucose-, and cell concentration-dependent manner. A mutant derivative unable to grow and form hyphae (SGY-243) migrates at a reduced rate. Concomitant to transendothelial migration, the permeability of the endothelial monolayer for dextran diffusion markers is significantly increased. This increase in transendothelial exchange occurs before fungal cells are detectable in the abluminal compartment and is time, glucose, and cell concentration dependent. A mutant strain (hOG301) unable to interact with endothelial cells does not alter endothelial permeability. Thus, transendothelial migration of C. albicans is able to damage the barrier function of an endothelial monolayer. Our experimental system, which reflects key stages of transendothelial migration of C. albicans including adherence and passage across endothelial cells and the extracellular matrix, may be a useful model for comparisons of transendothelial migration characteristics of Candida strains.

Full Text

The Full Text of this article is available as a PDF (590.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai T., Mikami Y., Yokoyama K. Phagocytosis of Candida albicans by rabbit alveolar macrophages and guinea pig neutrophils. Sabouraudia. 1977 Jul;15(2):171–177. [PubMed] [Google Scholar]
  2. Booyse F. M., Sedlak B. J., Rafelson M. E., Jr Culture of arterial endothelial cells: characterization and growth of bovine aortic cells. Thromb Diath Haemorrh. 1975 Dec 15;34(3):825–839. [PubMed] [Google Scholar]
  3. Cagliero E., Roth T., Roy S., Maiello M., Lorenzi M. Expression of genes related to the extracellular matrix in human endothelial cells. Differential modulation by elevated glucose concentrations, phorbol esters, and cAMP. J Biol Chem. 1991 Aug 5;266(22):14244–14250. [PubMed] [Google Scholar]
  4. Calderone R. A., Braun P. C. Adherence and receptor relationships of Candida albicans. Microbiol Rev. 1991 Mar;55(1):1–20. doi: 10.1128/mr.55.1.1-20.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Del Vecchio P. J., Siflinger-Birnboim A., Shepard J. M., Bizios R., Cooper J. A., Malik A. B. Endothelial monolayer permeability to macromolecules. Fed Proc. 1987 Jun;46(8):2511–2515. [PubMed] [Google Scholar]
  6. Edwards J. E., Jr, Mayer C. L., Filler S. G., Wadsworth E., Calderone R. A. Cell extracts of Candida albicans block adherence of the organisms to endothelial cells. Infect Immun. 1992 Aug;60(8):3087–3091. doi: 10.1128/iai.60.8.3087-3091.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Filler S. G., Ibe B. O., Luckett P. M., Raj J. U., Edwards J. E., Jr Candida albicans stimulates endothelial cell eicosanoid production. J Infect Dis. 1991 Nov;164(5):928–935. doi: 10.1093/infdis/164.5.928. [DOI] [PubMed] [Google Scholar]
  8. Filler S. G., Swerdloff J. N., Hobbs C., Luckett P. M. Penetration and damage of endothelial cells by Candida albicans. Infect Immun. 1995 Mar;63(3):976–983. doi: 10.1128/iai.63.3.976-983.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gow N. A., Robbins P. W., Lester J. W., Brown A. J., Fonzi W. A., Chapman T., Kinsman O. S. A hyphal-specific chitin synthase gene (CHS2) is not essential for growth, dimorphism, or virulence of Candida albicans. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6216–6220. doi: 10.1073/pnas.91.13.6216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gustafson K. S., Vercellotti G. M., Bendel C. M., Hostetter M. K. Molecular mimicry in Candida albicans. Role of an integrin analogue in adhesion of the yeast to human endothelium. J Clin Invest. 1991 Jun;87(6):1896–1902. doi: 10.1172/JCI115214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hostetter M. K. Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin Microbiol Rev. 1994 Jan;7(1):29–42. doi: 10.1128/cmr.7.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hostetter M. K., Lorenz J. S., Preus L., Kendrick K. E. The iC3b receptor on Candida albicans: subcellular localization and modulation of receptor expression by glucose. J Infect Dis. 1990 Apr;161(4):761–768. doi: 10.1093/infdis/161.4.761. [DOI] [PubMed] [Google Scholar]
  13. Hubbard M. J., Markie D., Poulter R. T. Isolation and morphological characterization of a mycelial mutant of Candida albicans. J Bacteriol. 1986 Jan;165(1):61–65. doi: 10.1128/jb.165.1.61-65.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hube B., Monod M., Schofield D. A., Brown A. J., Gow N. A. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol Microbiol. 1994 Oct;14(1):87–99. doi: 10.1111/j.1365-2958.1994.tb01269.x. [DOI] [PubMed] [Google Scholar]
  15. Ibrahim A. S., Mirbod F., Filler S. G., Banno Y., Cole G. T., Kitajima Y., Edwards J. E., Jr, Nozawa Y., Ghannoum M. A. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun. 1995 May;63(5):1993–1998. doi: 10.1128/iai.63.5.1993-1998.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jaffe E. A., Hoyer L. W., Nachman R. L. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest. 1973 Nov;52(11):2757–2764. doi: 10.1172/JCI107471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kelly R., Miller S. M., Kurtz M. B. One-step gene disruption by cotransformation to isolate double auxotrophs in Candida albicans. Mol Gen Genet. 1988 Sep;214(1):24–31. doi: 10.1007/BF00340174. [DOI] [PubMed] [Google Scholar]
  18. Kirsch D. R., Whitney R. R. Pathogenicity of Candida albicans auxotrophic mutants in experimental infections. Infect Immun. 1991 Sep;59(9):3297–3300. doi: 10.1128/iai.59.9.3297-3300.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Klotz S. A., Drutz D. J., Harrison J. L., Huppert M. Adherence and penetration of vascular endothelium by Candida yeasts. Infect Immun. 1983 Oct;42(1):374–384. doi: 10.1128/iai.42.1.374-384.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Klotz S. A., Maca R. D. Endothelial cell contraction increases Candida adherence to exposed extracellular matrix. Infect Immun. 1988 Sep;56(9):2495–2498. doi: 10.1128/iai.56.9.2495-2498.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Klotz S. A., Smith R. L., Stewart B. W. Effect of an arginine-glycine-aspartic acid-containing peptide on hematogenous candidal infections in rabbits. Antimicrob Agents Chemother. 1992 Jan;36(1):132–136. doi: 10.1128/aac.36.1.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mayer C. L., Filler S. G., Edwards J. E., Jr Candida albicans adherence to endothelial cells. Microvasc Res. 1992 Mar;43(2):218–226. doi: 10.1016/0026-2862(92)90018-k. [DOI] [PubMed] [Google Scholar]
  23. Nègre E., Vogel T., Levanon A., Guy R., Walsh T. J., Roberts D. D. The collagen binding domain of fibronectin contains a high affinity binding site for Candida albicans. J Biol Chem. 1994 Sep 2;269(35):22039–22045. [PubMed] [Google Scholar]
  24. Pendrak M. L., Klotz S. A. Adherence of Candida albicans to host cells. FEMS Microbiol Lett. 1995 Jun 15;129(2-3):103–113. doi: 10.1111/j.1574-6968.1995.tb07566.x. [DOI] [PubMed] [Google Scholar]
  25. Rotrosen D., Edwards J. E., Jr, Gibson T. R., Moore J. C., Cohen A. H., Green I. Adherence of Candida to cultured vascular endothelial cells: mechanisms of attachment and endothelial cell penetration. J Infect Dis. 1985 Dec;152(6):1264–1274. doi: 10.1093/infdis/152.6.1264. [DOI] [PubMed] [Google Scholar]
  26. Ruderman N. B., Williamson J. R., Brownlee M. Glucose and diabetic vascular disease. FASEB J. 1992 Aug;6(11):2905–2914. doi: 10.1096/fasebj.6.11.1644256. [DOI] [PubMed] [Google Scholar]
  27. Shepherd M. G. Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infections. Infect Immun. 1985 Nov;50(2):541–544. doi: 10.1128/iai.50.2.541-544.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Voyta J. C., Via D. P., Butterfield C. E., Zetter B. R. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol. 1984 Dec;99(6):2034–2040. doi: 10.1083/jcb.99.6.2034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Zink S., Rösen P., Sackmann B., Lemoine H. Regulation of endothelial permeability by beta-adrenoceptor agonists: contribution of beta 1- and beta 2-adrenoceptors. Biochim Biophys Acta. 1993 Sep 13;1178(3):286–298. doi: 10.1016/0167-4889(93)90206-5. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES